Induced Pluripotent Stem Cells (iPSCs) Derived 3D Human Lung Organoids from Different Ethnicities to Understand the SARS-CoV2 Severity/Infectivity Percentage
| Media Type: |
Electronic Article |
|---|
| Year of Publication: |
2021 |
|---|
| Contained In: |
Stem cell reviews and reports - Vol. 17, No. 1 (2021), p. 293-295 |
|---|
| Language: |
English |
|---|
| Contributors: |
|---|
| Links: |
|---|
| Keywords: |
3D human lung organoids |
|---|
| Notes: |
Date Revised 22.02.2021 published: Print Citation Status In-Data-Review Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine |
|---|
| Physical Description: |
Online-Ressource |
|---|
| doi: |
10.1007/s12015-020-09989-2 |
|---|---|
| PMID: |
32500482 |
| PPN (Catalogue-ID): |
NLM311695094 |
|---|
| LEADER | 01513nma a2200433 c 4500 | ||
|---|---|---|---|
| 001 | NLM311695094 | ||
| 003 | DE-601 | ||
| 005 | 20210222213727.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200605s2021 000 0 eng d | ||
| 024 | 7 | |a 10.1007/s12015-020-09989-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed21n1163.xml |
| 035 | |a (DE-599)NLM32500482 | ||
| 040 | |b ger |c GBVCP | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Bose, Bipasha | |
| 245 | 1 | 0 | |a Induced Pluripotent Stem Cells (iPSCs) Derived 3D Human Lung Organoids from Different Ethnicities to Understand the SARS-CoV2 Severity/Infectivity Percentage |h Elektronische Ressource |
| 300 | |a Online-Ressource | ||
| 500 | |a Date Revised 22.02.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status In-Data-Review | ||
| 500 | |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine | ||
| 611 | 2 | 7 | |a Letter |2 gnd |
| 655 | 7 | |a 3D human lung organoids |2 gnd | |
| 655 | 7 | |a SARS-CoV2 |2 gnd | |
| 655 | 7 | |a Severity/infectivity percentage |2 gnd | |
| 655 | 7 | |a iPSCs |2 gnd | |
| 689 | 0 | 0 | |A f |a Letter |
| 689 | 0 | |5 DE-601 | |
| 689 | 1 | 0 | |a 3D human lung organoids |
| 689 | 1 | 1 | |a SARS-CoV2 |
| 689 | 1 | 2 | |a Severity/infectivity percentage |
| 689 | 1 | 3 | |a iPSCs |
| 689 | 1 | |5 DE-601 | |
| 773 | 0 | 8 | |i in |t Stem cell reviews and reports |g Vol. 17, No. 1 (2021), p. 293-295 |q 17:1<293-295 |w (DE-601)NLM301123896 |x 2629-3277 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1007/s12015-020-09989-2 |3 Volltext |
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2021 |e 1 |b 28 |c 02 |h 293-295 | ||